SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending due to a significant European distribution partnership for its Anktiva cancer therapy, a critical FDA resubmission, and strong indications of major funding from Saudi Arabia. Investors are keenly watching for a potential short squeeze, fueled by enthusiasm for the drug's global market potential and ongoing discussions around US regulatory progress.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending following a significant stock drop sparked by its Q4 earnings, which revealed a net loss and weak guidance, intensifying community debate over the 'Buy Now, Pay Later' model's sustainability and the company's valuation after its already steep post-IPO decline.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL is trending after its NHS-Galleri cancer screening trial delivered mixed results, missing a primary endpoint but demonstrating promising early detection for several deadly cancers. The community is sharply divided, with some viewing the significant stock drop as an overreaction given the company's strong cash position and ongoing US FDA progress, while others see it as a justified response to the trial's outcome.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy ($SWEAT) is actively trending as its 'move-to-earn' model sparks ongoing debate within the crypto community. Many holders express optimism for a future rebound and are accumulating tokens despite a currently low valuation, while others remain skeptical of its long-term viability.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont is trending following its robust earnings report which was subsequently overshadowed by conservative 2026 gold production guidance and higher anticipated costs. This has sparked a sharp debate among investors, with some seeing a compelling buying opportunity while others express concern about future profitability despite strong gold prices.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is actively discussed after pricing a public stock offering at $5.45 and securing a royalty funding agreement, prompting a polarized community debate between significant dilution concerns and the strategic cash infusion to advance its promising prostate cancer BLA and broader oncology pipeline. The capital raises, including validation from RTW Investments, are viewed by some as crucial for accelerating regulatory milestones, while others express disappointment over the timing and share issuance.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems is seeing significant momentum following recent multi-million dollar contract wins from the U.S. Navy for P-8A Poseidon aircraft and a commercial robotics customer, solidifying its position in high-performance Edge AI for defense and industrial applications. The community is actively discussing its tight float, potential for a short squeeze, and substantial upside as a pure-play in the rapidly growing Edge AI sector, with expectations of larger military contracts on the horizon.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

The cryptocurrency $SATOSHI is trending as the community fervently champions its tokenization of Satoshi Nakamoto, viewing it as the ultimate, timeless narrative and foundational identity of the entire crypto industry. Supporters believe its limited supply and unparalleled significance position it as a monumental asset destined to eclipse other major tokens, representing a unique opportunity akin to being early on Bitcoin.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

WEEDCOIN is trending as its dedicated community, focused on cannabis culture and long-term building, anticipates the 4/20 event while promoting their Solana-based cryptocurrency with the mantra 'Like bitcoin but way higher' for its broader ecosystem integration.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending following a strategic partnership with Meta Platforms to build AI data centers and a reported significant investment in OpenAI, sparking community anticipation for upcoming earnings and new chip announcements to break its recent range, while many discuss perceived market manipulation holding the stock sideways.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NewEdge Wealth LLC Raises Stock Holdings in Amgen Inc. $AMGN

NewEdge Wealth LLC lifted its stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 3.1% in the third quarter, according to the company in its most recent filing with the Securities and...

Axxcess Wealth Management LLC Boosts Stock Position in Amgen Inc. $AMGN

Axxcess Wealth Management LLC boosted its stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 59.0% in the third quarter, according to the company in its most recent 13F filing with the...

Hodges Capital Management Inc. Sells 6,887 Shares of Amgen Inc. $AMGN

Hodges Capital Management Inc. reduced its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 58.6% during the third quarter, according to the company in its most recent filing with the Securities...

Amgen Details Oncology R&D Push, IMDELLTRA Expansion and LUMAKRAS Updates at Citi Summit

Amgen (NASDAQ:AMGN) executives outlined the company's oncology research and development priorities and provided updates on several key programs during Citi's Virtual Oncology Leadership Summit...

Dow Jones 101: How many stocks are in the Dow in 2026?

U.S. stock indexes are recognized globally, and the oldest and perhaps most famous is the Dow Jones Industrial Average. The Dow, as it's popularly known, started off as an index of 12...

Rothschild & Co Redburn Boosts Amgen (NASDAQ:AMGN) Price Target to $200.00

Rothschild & Co Redburn raised their target price on shares of Amgen from $180.00 to $200.00 and gave the company a "sell" rating in a research report on Wednesday...

First National Bank of Omaha Purchases Shares of 40,836 Amgen Inc. $AMGN

First National Bank of Omaha purchased a new stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The...

Crestwood Advisors Group LLC Boosts Stake in Amgen Inc. $AMGN

Crestwood Advisors Group LLC raised its stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 26.2% in the third quarter, according to the company in its most recent disclosure with the...

NEOS Investment Management LLC Increases Stock Position in Amgen Inc. $AMGN

NEOS Investment Management LLC boosted its position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 48.4% in the third quarter, according to the company in its most recent 13F filing with the...

Skandinaviska Enskilda Banken AB publ Lowers Stake in Amgen Inc. $AMGN

Skandinaviska Enskilda Banken AB publ reduced its stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 36.7% in the third quarter, according to its most recent filing with the SEC. The fund...

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Current Price	$375.50
Prev Close	$379.73
Open	$377.91
Dividend Yield	2.91%
50-Day Moving Average	$339.36
Beta	0.51
Avg. Volume	2.75M
PE Ratio	26.68

52-Week High	$385.12
52-Week Low	$261.43
Market Capitalization	$204.7B
EPS (Annual)	$14.23
Price to Book	23.63
Revenue Per Employee	$1.17M

AMGN
AMGEN Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AMGN News

AMGNAMGEN Inc.